1. Elevation of brain GABA concentrations with amino-oxyacetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
- Author
-
Green AR, Tordoff AF, and Bloomfield MR
- Subjects
- Animals, Dopamine metabolism, Humans, Hyperkinesis chemically induced, Male, Norepinephrine metabolism, Picrotoxin pharmacology, Rats, Syndrome, Tranylcypromine pharmacology, Tryptophan pharmacology, Acetates pharmacology, Aminobutyrates metabolism, Aminooxyacetic Acid pharmacology, Brain drug effects, Hyperkinesis drug therapy, Serotonin biosynthesis, gamma-Aminobutyric Acid metabolism
- Abstract
Pretreatment of rats with aminooxyacetic acid (AOAA; 40 mg/kg) raised the concentration of rat brain GABA and inhibited the hyperactivity produced by increasing brain 5-hydroxytryptamine (5-HT) concentration by administration of tranylcypromine and L-tryptophan. The maximum effect was seen 90 min after AOAA injection with smaller effects 30 and 180 min after injection. AOAA did not affect the rate of 5-HT accumulation in the brain, but did inhibit the hyperactivity response which follows injection of the 5-HT agonist 5-methoxy-N,N-dimethyltryptamine, suggesting that post-synaptic 5-HT responses were being inhibited. AOAA also inhibited the locomotor activity which follows administration of tranylcypromine and L-dopa. Blockade of GABA receptors by injection of picrotoxin (2.5 mg/kg) enhanced the dopamine hyperactivity. Since a dopaminergic system has been shown to be involved in the 5-HT hyperactivity syndrome and appears to act post-synaptically to the 5-HT neurones initiating the syndrome it is suggested that inhibition of the 5-HT hyperactivity syndrome may be due to accumulation of GABA distal to the dopaminergic receptors.
- Published
- 1976
- Full Text
- View/download PDF